| [1] | Peipei GUO, Yang XU, Jiaqi SHI, Yang WU, Lixia LU, Bin LI, Xiaohui YU. Role of amino acid metabolism in autoimmune hepatitis and related therapeutic targets[J]. Journal of Clinical Hepatology, 2025, 41(3): 547-551. doi: 10.12449/JCH250323 |
| [2] | Yao MA, Ting LI, Qiushi ZHANG, Ling HU, Jie. ZHENG. Construction and validation of a risk prediction model for postoperative delirium in primary liver cancer patients aged 60 years or older[J]. Journal of Clinical Hepatology, 2024, 40(9): 1816-1821. doi: 10.12449/JCH240916 |
| [3] | Hongyu XIANG, Zheng DANG, Shulin XU, Gang NIU, Yuesheng LI, Baiwen MIAO, Yaoping PANG, Ruifang FAN, Jianwei QIN. A multivariate analysis of acute severe cholangitis and the establishment and evaluation of a risk prediction scoring model[J]. Journal of Clinical Hepatology, 2022, 38(8): 1847-1853. doi: 10.3969/j.issn.1001-5256.2022.08.024 |
| [4] | Yebei LIANG, Chunguang YANG, Huadong ZENG, Ruwei TAO, Qiuming HU, Xiaoying TANG, Huaxiang SHI, Wei WU, Xuhong HOU, Weiping JIA. Establishment of screening models for nonalcoholic fatty liver disease in the adult Blang population[J]. Journal of Clinical Hepatology, 2021, 37(12): 2861-2868. doi: 10.3969/j.issn.1001-5256.2021.12.025 |
| [5] | Lin DongYi, Peng Bo, Zheng JingHui, Wang ZongYu, Li HanZhong, He JianBo, Li KeZhi, Wu GuoBin, Chen Chuang. Value of a logistic regression model based on the clinical features of liver cancer in judging the traditional Chinese medicine syndrome types of primary liver cancer[J]. Journal of Clinical Hepatology, 2020, 36(6): 1293-1298. doi: 10.3969/j.issn.1001-5256.2020.06.021 |
| [6] | Huang YunYi, Wang XianBo. Establishment of a predictive model of death within 30 days for patients with liver cirrhosis and bacterial ascites[J]. Journal of Clinical Hepatology, 2019, 35(11): 2472-2477. doi: 10.3969/j.issn.1001-5256.2019.11.017 |
| [7] | Liu HaiFeng, Xu YongSheng, Zhang Yue, Zhao XiaoJu, Liu Zhao, Li JinKui, Yan RuiFeng, Xu Kai, Lei JunQiang. Value of magnetic resonance morphological imaging in the diagnosis and differentiation of post-hepatitis B cirrhosis[J]. Journal of Clinical Hepatology, 2018, 34(12): 2587-2591. doi: 10.3969/j.issn.1001-5256.2018.12.016 |
| [8] | Wu Jing, Meng QingHua, Xue Ran. Effect of tumor-stroma crosstalk on amino acid metabolism in hepatic stellate cells[J]. Journal of Clinical Hepatology, 2018, 34(12): 2610-2613. doi: 10.3969/j.issn.1001-5256.2018.12.020 |
| [9] | Lu: Zheng, Meng QingHua. Progress in application of branched- chain amino acids in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2015, 31(3): 475-477. doi: 10.3969/j.issn.1001-5256.2015.03.040 |
| [10] | Sun YuMei, Zhou YingXia, Xing HuiChun, Lin KeKe. Clock drawing test in cognitive assessment for patients with hepatitis B cirrhosis[J]. Journal of Clinical Hepatology, 2015, 31(3): 413-417. doi: 10.3969/j.issn.1001-5256.2015.03.024 |
| [11] | Zhang XueHua, Li ZhongPing. Clinical value of nucleotide analogues for treatment of hepatitis B-related decompensated cirrhosis[J]. Journal of Clinical Hepatology, 2015, 31(3): 365-369. doi: 10.3969/j.issn.1001-5256.2015.03.012 |
| [12] | Zhao YuPing, Han XiuQing, Xue ShuBao, Xiao FengYan, Gao CuiHong, Zhao LiMei. Clinical analysis of blood amino acids and trace elements in patients with hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2015, 31(6): 915-917. doi: 10.3969/j.issn.1001-5256.2015.06.021 |
| [13] | Gao Rui, Liu ZhongJing, Chen Fei, Gao Lei, Jiang ChuanWu. Multivariate regression analysis of risk factors for HBV-related primary liver cancer[J]. Journal of Clinical Hepatology, 2014, 30(4): 370-372. doi: 10.3969/j.issn.1001-5256.2014.04.021 |
| [14] | Gu LiLi, Wang XianBo. Research progress in noninvasive regression models for liver fibrosis in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2014, 30(7): 691-694. doi: 10.3969/j.issn.1001-5256.2014.07.032 |
| [15] | Cui YanPing, Liu FengHua, Shi QingFeng, Zhao HongKui, Wang SiKui. Logistic regression analysis of prognostic factors in 106 acute-on-chronic liver failure patients with hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2014, 30(10): 992-995. doi: 10.3969/j.issn.1001-5256.2014.10.005 |
| [16] | Zhang ZhiHong, Ni BingQiang, Chen RiXin. Protective effect of Ornithine Aspartate on chemotherapy of gastrointestinal tumors with HBV infection[J]. Journal of Clinical Hepatology, 2011, 27(2): 148-150+160. |
| [17] | Chen FangZhi, Li GuoQing, Zhang Li, Liu HongYing. Clinical effect of entecavir in patients with decompensated hepatitis B cirrhosis[J]. Journal of Clinical Hepatology, 2010, 26(6): 608-609+612. |
DownLoad: